ArticleIEEE transactions on medical imaging2025
Deep Learning Enables Fast and Accurate Quantification of MRI-Guided Near-Infrared Spectral Tomography for Breast Cancer Diagnosis.
Article in IEEE transactions on medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The utilization of magnetic resonance (MR) imaging to guide near-infrared spectral tomography (NIRST) shows significant potential for improving the specificity and sensitivity of breast cancer diagnosis. However, the efficiency and accuracy of NIRST image reconstruction have been limited by the complexities of light propagation modeling and MRI image segmentation. To address these challenges, we developed and evaluated a deep learning-based approach for MR-guided 3D NIRST image reconstruction (DL-MRg-NIRST). Using a network trained on synthetic data, the DL-MRg-NIRST system reconstructed images from data acquired during 38 clinical imaging exams of patients with breast abnormalities. Statistical analysis of the results demonstrated a sensitivity of 87.5%, a specificity of 92.9%, and a diagnostic accuracy of 89.5% in distinguishing pathologically defined benign from malignant lesions. Additionally, the combined use of MRI and DL-MRg-NIRST diagnoses achieved an area under the receiver operating characteristic (ROC) curve of 0.98. Remarkably, the DL-MRg-NIRST image reconstruction process required only 1.4 seconds, significantly faster than state-of-the-art MR-guided NIRST methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.